Propel Bio Management, LLC Agios Pharmaceuticals, Inc. Transaction History
Propel Bio Management, LLC
- $172 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding AGIO
# of Institutions
231Shares Held
58.1MCall Options Held
403KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$190 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$186 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$163 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$125 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$95 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.84B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...